SoliPharma develops and markets brand and generic drug products. Our target markets span across various geographic areas, primarily the US, China, Latin America and south Asia. We specialize in niche products for anti-infectious/immunosuppressant, respiratory/allergy and anesthetic/pain management.

Market Presence
  • United States
  • China
  • Rest of World
Quality System
  • US FDA GMP Inspected
  • China NMPA GMP Inspected
  • CNAS ISO17025 Certified
Therapeutic Area
  • Anti-infection/Immunosuppressant
  • Hematology/Blood disorder
  • Respiratory/Allergy